Linda S Wood1, Eve H Pickering, Bryan M Dechairo. 1. Pharmacogenomics Molecular Profiling, Pfizer Global Research and Development, Groton, Connecticut 06340, USA. Linda.s.wood@pfizer.com
Abstract
BACKGROUND: Schizophrenia is a complex psychiatric disorder with a strong genetic component. Past linkage studies have implicated several chromosomal regions in the etiology of schizophrenia. Within these regions, several genes have been identified via candidate gene association studies as strong schizophrenia susceptibility loci, including DAO, DAOA, DISC1, DTNBP1, and RGS4. METHODS: The present study attempted to replicate these association findings by analyzing a total of 120 markers across these genes in 311 schizophrenia subjects, 140 schizoaffective subjects, and 291 control subjects. RESULTS: Our study found no association for DAOA and DTNBP1 with schizophrenia. Although no association was seen with DAOA and DTNBP1, several other markers in the other genes resulted in significant association with schizophrenia (p < .05). However, after a conservative Bonferroni correction for multiple testing, only one marker, rs3918346, within DAO remained significant (odds ratio = 1.71, confidence interval = 1.32-2.22, p = 4 x 10(-5)). This significant association was concordant with previous DAO genetic findings. CONCLUSIONS: Our results significantly support DAO as a susceptibility locus for schizophrenia and offer some support for the implication of both RGS4 and DISC1 in the etiology of schizophrenia. However, we see no evidence to support either DAOA or DTNBP1 as schizophrenia disease loci.
BACKGROUND:Schizophrenia is a complex psychiatric disorder with a strong genetic component. Past linkage studies have implicated several chromosomal regions in the etiology of schizophrenia. Within these regions, several genes have been identified via candidate gene association studies as strong schizophrenia susceptibility loci, including DAO, DAOA, DISC1, DTNBP1, and RGS4. METHODS: The present study attempted to replicate these association findings by analyzing a total of 120 markers across these genes in 311 schizophrenia subjects, 140 schizoaffective subjects, and 291 control subjects. RESULTS: Our study found no association for DAOA and DTNBP1 with schizophrenia. Although no association was seen with DAOA and DTNBP1, several other markers in the other genes resulted in significant association with schizophrenia (p < .05). However, after a conservative Bonferroni correction for multiple testing, only one marker, rs3918346, within DAO remained significant (odds ratio = 1.71, confidence interval = 1.32-2.22, p = 4 x 10(-5)). This significant association was concordant with previous DAO genetic findings. CONCLUSIONS: Our results significantly support DAO as a susceptibility locus for schizophrenia and offer some support for the implication of both RGS4 and DISC1 in the etiology of schizophrenia. However, we see no evidence to support either DAOA or DTNBP1 as schizophrenia disease loci.
Authors: Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Gregory J Burrell; Aaron J Krasner; Daniel B Schwartz; Pablo V Gejman Journal: Hum Hered Date: 2007-05-02 Impact factor: 0.444
Authors: Kristin K Nicodemus; Joseph H Callicott; Rachel G Higier; Augustin Luna; Devon C Nixon; Barbara K Lipska; Radhakrishna Vakkalanka; Ina Giegling; Dan Rujescu; David St Clair; Pierandrea Muglia; Yin Yao Shugart; Daniel R Weinberger Journal: Hum Genet Date: 2010-04 Impact factor: 4.132
Authors: Liisa Tomppo; William Hennah; Jouko Miettunen; Marjo-Riitta Järvelin; Juha Veijola; Samuli Ripatti; Päivi Lahermo; Dirk Lichtermann; Leena Peltonen; Jesper Ekelund Journal: Arch Gen Psychiatry Date: 2009-02
Authors: Gregor Habl; Mathias Zink; Georg Petroianu; Manfred Bauer; Thomas Schneider-Axmann; Martina von Wilmsdorff; Peter Falkai; Fritz A Henn; Andrea Schmitt Journal: J Neural Transm (Vienna) Date: 2009-10-13 Impact factor: 3.575
Authors: Sarah M Hartz; Beng-Choon Ho; Nancy C Andreasen; Amy Librant; Danielle Rudd; Eric A Epping; Thomas H Wassink Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2010-03-05 Impact factor: 3.568
Authors: Sarah E Bergen; Ayman H Fanous; Po-Hsiu Kuo; Brandon K Wormley; F Anthony O'Neill; Dermot Walsh; Brien P Riley; Kenneth S Kendler Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2010-03-05 Impact factor: 3.568